Efficacy of Fenoverine and Trimebutine in the Management of Irritable Bowel Syndrome: Multicenter Randomized Double-blind Non-inferiority Clinical Study

Clinical Study ◽

Double Blind ◽

374 Effects of low-FODMAP and gluten-free diets in Irritable Bowel Syndrome patients. A double-blind randomized controlled clinical study

Gastrointestinal Endoscopy ◽

10.1016/j.gie.2014.02.1020 ◽

2014 ◽

Vol 79 (5) ◽

pp. AB402

Author(s):

Daria Piacentino ◽

Sara Rossi ◽

Valeria Alvino ◽

Rosanna Cantarini ◽

Danilo Badiali ◽

...

Keyword(s):

Clinical Study ◽

Gluten Free ◽

Double Blind ◽

Randomized Controlled ◽

Irritable Bowel ◽

Controlled Clinical Study

374 Effects of Low-Fodmap and Gluten-Free Diets in Irritable Bowel Syndrome Patients. A Double-Blind Randomized Controlled Clinical Study

Gastroenterology ◽

10.1016/s0016-5085(14)60294-8 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-82 ◽

Cited By ~ 3

Author(s):

Daria Piacentino ◽

Sara Rossi ◽

Valeria Alvino ◽

Rosanna Cantarini ◽

Danilo Badiali ◽

...

Keyword(s):

Clinical Study ◽

Gluten Free ◽

Double Blind ◽

Randomized Controlled ◽

Irritable Bowel ◽

Controlled Clinical Study

Prescript-assist™ probiotic-prebiotic treatment for irritable bowel syndrome: A methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.06.005 ◽

2005 ◽

Vol 27 (6) ◽

pp. 755-761 ◽

Cited By ~ 41

Author(s):

Alvah C. Bittner ◽

Robert M. Croffut ◽

Mary C. Stranahan

Keyword(s):

Clinical Study ◽

Double Blind ◽

A double‐blind, randomized, controlled clinical study to evaluate the properties of Saccharomyces cerevisiae CNCM I‐ 3856 on Irritable Bowel Syndrome management

The FASEB Journal ◽

10.1096/fasebj.26.1_supplement.373.5 ◽

2012 ◽

Vol 26 (S1) ◽

Author(s):

Pierre Desreumaux ◽

Béatrice Housez ◽

Murielle Cazaubiel ◽

Fanny Pelerin ◽

Peter Jüsten

Keyword(s):

Saccharomyces Cerevisiae ◽

Clinical Study ◽

Double Blind ◽

Randomized Controlled ◽

Irritable Bowel ◽

Controlled Clinical Study

Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study

Food & Nutrition Research ◽

10.29219/fnr.v62.1218 ◽

2018 ◽

Vol 62 (0) ◽

Cited By ~ 30

Author(s):

Muhammed Majeed ◽

Kalyanam Nagabhushanam ◽

Sivakumar Arumugam ◽

Shaheen Majeed ◽

Furqan Ali

Keyword(s):

Clinical Study ◽

Major Depression ◽

Bacillus Coagulans ◽

Double Blind ◽

Double Blind Placebo ◽

Pilot Clinical Study ◽

Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study

Nutrition Journal ◽

10.1186/s12937-016-0140-6 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 28

Author(s):

Muhammed Majeed ◽

Kalyanam Nagabhushanam ◽

Sankaran Natarajan ◽

Arumugam Sivakumar ◽

Furqan Ali ◽

...

Keyword(s):

Clinical Study ◽

Bacillus Coagulans ◽

Double Blind ◽

Pilot Clinical Study ◽

The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled study

Clinical Gastroenterology and Hepatology ◽

10.1053/cgh.2003.50032 ◽

2003 ◽

Vol 1 (3) ◽

pp. 219-228 ◽

Cited By ~ 19

Author(s):

Sjoerd D. Kuiken ◽

Guido N. J. Tytgat ◽

Guy E. E. Boeckxstaens

Keyword(s):

Selective Serotonin Reuptake Inhibitor ◽

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Selective Serotonin ◽

Controlled Study ◽

Serotonin Reuptake Inhibitor ◽

Double Blind ◽

Faculty Opinions recommendation of VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6520956.6651054 ◽

2010 ◽

Author(s):

Carlo Di Lorenzo

Keyword(s):

Crossover Study ◽

Double Blind ◽

Irritable Bowel ◽

Blind Crossover Study ◽

Double Blind Crossover Study

Faculty Opinions recommendation of Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958672.793516776 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737113055.793574215 ◽

2020 ◽

Author(s):

Ian Beales

Keyword(s):

Controlled Study ◽

Faecal Microbiota ◽

Double Blind ◽

Double Blind Placebo ◽

Faecal Microbiota Transplantation ◽